tetano
Editor, Senior Moderator
J Rheumatol
. 2022 Aug 15;jrheum.220219.
doi: 10.3899/jrheum.220219. Online ahead of print.
Adult-Onset Still Disease After ChadOx1 nCOV-19 Vaccination
Jian Weng[SUP] 1 [/SUP], Linghong Linda Zhou[SUP] 1 [/SUP], Thomas Hahn[SUP] 1 [/SUP], Kamran Shojania[SUP] 1 [/SUP], Jan Dutz[SUP] 1 [/SUP]
Affiliations
Abstract
We report a case of adult-onset Still disease (AOSD) after ChadOx1 nCOV-19/AZD1222 coronavirus disease 2019 (COVID-19) vaccine (AstraZeneca).A 51-year-old female received her first AZD1222 vaccine in spring of 2021.
. 2022 Aug 15;jrheum.220219.
doi: 10.3899/jrheum.220219. Online ahead of print.
Adult-Onset Still Disease After ChadOx1 nCOV-19 Vaccination
Jian Weng[SUP] 1 [/SUP], Linghong Linda Zhou[SUP] 1 [/SUP], Thomas Hahn[SUP] 1 [/SUP], Kamran Shojania[SUP] 1 [/SUP], Jan Dutz[SUP] 1 [/SUP]
Affiliations
- PMID: 35970527
- DOI: 10.3899/jrheum.220219
Abstract
We report a case of adult-onset Still disease (AOSD) after ChadOx1 nCOV-19/AZD1222 coronavirus disease 2019 (COVID-19) vaccine (AstraZeneca).A 51-year-old female received her first AZD1222 vaccine in spring of 2021.